Doctor Medisciences (India) Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 16-11-2024
- Paid Up Capital ₹ 4.50 M
as on 16-11-2024
- Company Age 13 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 3.00 M
as on 16-11-2024
- Revenue 23.91%
(FY 2023)
- Profit -16.61%
(FY 2023)
- Ebitda 46.41%
(FY 2023)
- Net Worth 5.47%
(FY 2023)
- Total Assets 11.36%
(FY 2023)
About Doctor Medisciences (India)
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 4.50 M.
The company currently has active open charges totaling ₹3.00 M.
Sunil Chandak and Rekha Chandak serve as directors at the Company.
- CIN/LLPIN
U24233MH2011PTC215371
- Company No.
215371
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
28 Mar 2011
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Doctor Medisciences (India)?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sunil Chandak  | Director | 28-Mar-2011 | Current |
| Rekha Chandak | Director | 28-Mar-2011 | Current |
Financial Performance of Doctor Medisciences (India).
Doctor Medisciences (India) Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 23.91% increase. The company also saw a substantial fall in profitability, with a 16.61% decrease in profit. The company's net worth moved up by a moderate rise of 5.47%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Doctor Medisciences (India)?
In 2023, Doctor Medisciences (India) had a promoter holding of 46.67% and a public holding of 53.33%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Shri Ram Super Speciality Surgical Centre Private LimitedActive 15 years 7 monthsSunil Chandak and Rekha Chandak are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
State Bank Of India Creation Date: 11 Jan 2012 | ₹3.00 M | Open |
How Many Employees Work at Doctor Medisciences (India)?
Unlock and access historical data on people associated with Doctor Medisciences (India), such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Doctor Medisciences (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Doctor Medisciences (India)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
